Title :

Risk-benefit ratio for TSH- suppressive Levothyroxine therapy in differentiated thyroid cancer

Author(s) :

Do Cao, Christine [Auteur]
Wemeau, Jean-Louis [Auteur]

Journal title :

Annales d'endocrinologie

Abbreviated title :

Ann Endocrinol.

Volume number :

76

Pages :

1S47-1S52

Publication date :

2015-02-01

ISSN :

0003-4266

Keyword(s) :

Mesh:Prognosis
Mesh:Humans
Mesh:Thyroxine/administration & dosage
Mesh:Quality of Life
Mesh:Risk Assessment
Mesh:Thyrotropin/antagonists & inhibitors*
Mesh:Middle Aged
Mesh:Thyroid Neoplasms/pathology*
Mesh:Thyroid Neoplasms/drug therapy*
Mesh:Hyperthyroidism/complications
Mesh:Osteoporosis/chemically induced
Mesh:Bone Diseases/chemically induced
Mesh:Cardiovascular Diseases/chemically induced
Mesh:Thyroxine/therapeutic use*
Mesh:Thyroxine/adverse effects
Mesh:Female
Mesh:Aged
Mesh:Atrial Fibrillation/chemically induced
Thyroid cancer
TSH
Suppressive
Therapy
Adverse effects
Levothyroxine

HAL domain(s) :

Sciences du Vivant [q-bio]

Language :

Anglais

Audience :

Internationale

Popular science :

Non

Administrative institution(s) :

Inserm
Université de Lille
CHU Lille

Collections :

• Lille Inflammation Research International Center (LIRIC) - U995

Research team(s) :

Immunity, inflammation and fibrsis in auto and allo-reactivity

Submission date :

2019-03-01T15:15:55Z